111

BIONET CORP

No trades
See on Supercharts
Market capitalization
‪2.79 B‬TWD
‪78.40 M‬TWD
‪1.13 B‬TWD
‪40.87 M‬
Beta (1Y)
0.14

About BIONET CORP

CEO
Tien Lai Liu
Headquarters
Taipei
Founded
2000
ISIN
TW0001784007
FIGI
BBG000QQCB05
Bionet Corp. engages in the businesses of cell therapy, regenerative medicine and medical big data. Its services and products include cell storage & application services, prenatal testing, and biotechnology medical beauty care products. The company was founded on August 17, 2000 and is headquartered in Taipei, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 1784 is 64.1 TWD — it has increased by 5.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange BIONET CORP stocks are traded under the ticker 1784.
BIONET CORP is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
1784 stock is 8.21% volatile and has beta coefficient of 0.14. Check out the list of the most volatile stocks — is BIONET CORP there?
Yes, you can track BIONET CORP financials in yearly and quarterly reports right on TradingView.
1784 stock has risen by 0.79% compared to the previous week, the month change is a 0.62% fall, over the last year BIONET CORP has showed a 12.46% increase.
1784 net income for the last quarter is ‪5.12 M‬ TWD, while the quarter before that showed ‪18.65 M‬ TWD of net income which accounts for −72.55% change. Track more BIONET CORP financial stats to get the full picture.
Today BIONET CORP has the market capitalization of ‪2.88 B‬, it has decreased by 0.45% over the last week.
Yes, 1784 dividends are paid annually. The last dividend per share was 0.70 TWD. As of today, Dividend Yield (TTM)% is 1.15%. Tracking BIONET CORP dividends might help you take more informed decisions.
BIONET CORP dividend yield was 1.22% in 2023, and payout ratio reached 42.59%. The year before the numbers were 1.59% and 86.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 1784 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIONET CORP stock right from TradingView charts — choose your broker and connect to your account.
1784 reached its all-time high on Jul 25, 2007 with the price of 151.2 TWD, and its all-time low was 14.9 TWD and was reached on Feb 8, 2006.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIONET CORP technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIONET CORP stock shows the strong buy signal. See more of BIONET CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIONET CORP EBITDA is ‪124.30 M‬ TWD, and current EBITDA margin is 11.03%. See more stats in BIONET CORP financial statements.